Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Organic acidemias (OA) are rare autosomal recessive metabolic disorders.
• OA lead to systemic organic acid elevation, metabolic instability, and multisystemic complications.
• Current therapies, including diet and cofactors, are insufficient for many patients.

Purpose of the Study:

• To review gene therapy approaches for organic acidemias.
• To illustrate experimental paradigms using methylmalonic acidemia (MMA) and propionic acidemia (PA) mouse models.
• To explore the potential of gene therapy as a new treatment for OA.

Main Methods:

• Review of gene therapy experiments in MMA and PA mouse models.
• Analysis of experimental paradigms for treating OA.
• Evaluation of liver transplantation as a precursor to gene therapy.

Main Results:

• Gene therapy approaches have been explored in relevant animal models for OA.
• MMA and PA mouse models have been used to test gene therapy strategies.
• Experimental paradigms from these models may be applicable to all forms of OA.

Conclusions:

• Gene therapy holds theoretical promise for treating OA.
• Liver transplantation can improve metabolic stability in severe OA cases.
• Further research in animal models is crucial for developing effective gene therapies for OA.